JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.17% |
| 2 | Financials | 10.12% |
| 3 | Consumer Discretionary | 9.84% |
| 4 | Healthcare | 7.97% |
| 5 | Communication Services | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
PUT
Chubb
CB
$133B
| $3.01M | ﹤0.01% |
10,900
| – | – |
|
|
DX
3702
Dynex Capital
DX
$3.24B
| $3M | ﹤0.01% |
237,316
-152,784
| -39% | -$1.9M |
|
|
THS
3703
DELISTED
Treehouse Foods
THS
| $2.99M | ﹤0.01% |
85,053
-231,375
| -73% | -$8.43M |
|
|
LGO
3704
Largo
LGO
$74.1M
| $2.99M | ﹤0.01% |
193,425
-6,748
| -3% | -$13.8K |
|
3705
PUT
PPG Industries
PPG
$25.4B
| $2.99M | ﹤0.01% |
25,000
| – | – |
|
3706
NCR Voyix
VYX
$1.13B
| $2.99M | ﹤0.01% |
215,753
+9,881
| +5% | +$137K |
|
3707
First Trust AAA CMBS ETF
CAAA
$35.4M
| $2.98M | ﹤0.01% |
147,833
| – | – |
|
3708
Kforce
KFRC
$1.04B
| $2.98M | ﹤0.01% |
52,511
+10,565
| +25% | +$614K |
|
|
AXON
3709
CALL
Axon Enterprise
AXON
$49.8B
| $2.97M | ﹤0.01% |
5,000
-20,000
| -80% | -$10.9M |
|
|
AXON
3710
PUT
Axon Enterprise
AXON
$49.8B
| $2.97M | ﹤0.01% |
+5,000
| New | +$2.72M |
|
3711
Sturm, Ruger & Co
RGR
$602M
| $2.97M | ﹤0.01% |
83,940
+23,081
| +38% | +$898K |
|
|
NXDR
3712
Nextdoor Holdings
NXDR
$998M
| $2.97M | ﹤0.01% |
1,252,571
+527,226
| +73% | +$1.31M |
|
3713
CALL
BILL Holdings
BILL
$4.96B
| $2.96M | ﹤0.01% |
+35,000
| New | +$2.61M |
|
|
3714
PUT
BILL Holdings
BILL
$4.96B
| $2.96M | ﹤0.01% |
+35,000
| New | +$2.61M |
|
3715
dLocal
DLO
$4.17B
| $2.96M | ﹤0.01% |
262,951
-230,238
| -47% | -$2.32M |
|
|
SRTA
3716
Strata Critical Medical Inc
SRTA
$522M
| $2.96M | ﹤0.01% |
695,536
-25,543
| -4% | -$97.2K |
|
3717
EyePoint Inc
EYPT
$1.27B
| $2.95M | ﹤0.01% |
395,444
+23,686
| +6% | +$220K |
|
|
SEMR
3718
DELISTED
Semrush
SEMR
| $2.94M | ﹤0.01% |
247,735
-139,256
| -36% | -$1.87M |
|
3719
Claros Mortgage Trust
CMTG
$257M
| $2.94M | ﹤0.01% |
649,674
+170,244
| +36% | +$1.06M |
|
3720
Arbutus Biopharma
ABUS
$924M
| $2.93M | ﹤0.01% |
896,258
+806,672
| +900% | +$2.97M |
|
3721
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$2.97B
| $2.93M | ﹤0.01% |
95,268
+12,963
| +16% | +$399K |
|
3722
Weave Communications
WEAV
$437M
| $2.92M | ﹤0.01% |
183,406
+38,729
| +27% | +$545K |
|
3723
Tiptree Inc
TIPT
$672M
| $2.92M | ﹤0.01% |
139,797
+60,595
| +77% | +$1.27M |
|
3724
Scholar Rock
SRRK
$6.4B
| $2.91M | ﹤0.01% |
67,271
+28,545
| +74% | +$929K |
|
3725
Equinor
EQNR
$96.8B
| $2.91M | ﹤0.01% |
122,652
+28,385
| +30% | +$682K |
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 510 new, 3,353 increased, 2,466 reduced and 523 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 510 new positions and closed 523 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.